Poly Medicure DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.76×	0.76×	0.76×	0.76×
	1.25×	1.29×	1.21×	1.16×	1.13×
	16.7%	17.4%	22.2%	21.4%	18.7%
	0.53×	0.53×	0.66×	0.80×	0.76×
	1.24×	1.24×	1.15×	1.26×	1.27×
	10.3%	11.3%	15.4%	19.0%	15.5%
	11.0%	11.0%	16.0%	19.1%	15.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

POLYMED₹1,461.90

Poly Medicure Ltd.

· Pharma & Health

₹ CrorePeersPFIZER RAINBOW ONESOURCE KIMS JUBLPHARMA VIJAYA INDGN GRANULESMcap ₹14,818 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.76	0.76	0.76	0.76	0.75
Interest Burden (Pretax/EBIT) ×	1.13	1.16	1.21	1.29	1.25
EBIT Margin %	18.67	21.39	22.17	17.43	16.68
Asset Turnover ×	0.76	0.80	0.66	0.53	0.53
Financial Leverage (Assets/Equity) ×	1.27	1.26	1.15	1.24	1.24
ROE (5-step product, year-end total equity) %	15.52	18.99	15.45	11.28	10.33
ROE (owners' profit / average owners' equity) %	15.39	19.05	15.99	10.97	10.97

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.